Upsher-Smith launches generic AccutaneIsotretinoin capsules are indicated for severe recalcitrant nodular acne. Walgreens Boots Alliance sells shares of AmerisourceBergenWalgreens Boots Alliance sold shares of AmerisourceBergen common stock through a registered public offering of approximately $1.6 billion. AmerisourceBergen also announced a registered public offering of 10.5 million shares of common stock. Buoyed by higher prices, Haleon raises forecast According to a Financial Times report, Haleon reported better-than-expected sales on well-known products despite higher prices. Nirvana Water Sciences secures $2.625M investment Through this investment, the company will look to support a new joint venture with Inspire Health Alliance, a healthcare services network. Xiromed intros generic Akovaz Generic Akovaz is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. Teva, Alvotech expand biosimilars partnership agreement Teva will exclusively commercialize two new biosimilar candidates and two line extensions of current biosimilars in the U.S., developed and manufactured by Alvotech. Walgreens Boots Alliance announces CFO transition James Kehoe is departing as global CFO; Manmohan Mahajan has been named interim global CFO. Natco obtains FDA nod for generic Lonsurf Generic Lonsurf is indicated primarily for the treatment of colorectal cancer. Aurobindo’s CuraTeQ Biologics subsidiary inks deal with BioFactura The exclusive license agreement with BioFactura is for a proposed Stelara biosimilar. Teva reportedly considering sale of $2B Active Ingredients unit Teva’s active pharmaceutical ingredients business comprises more than 400 APIs used in drugs to treat a wide range of diseases. First Previous 40 41 42 43 44 Next Last
